FIELD: chemistry.
SUBSTANCE: invention relates to 2-({[(2-cyano-4-methoxyphenyl)acetyl](3-phenylpropyl)-amino}methyl)-N-(dimethylsulphamoyl)-5-methyl-1,3-thiazol-4-carboxamide or pharmaceutically acceptable salt thereof, which is used as an active ingredient of a pharmaceutical composition for treating diseases caused by lysophosphatidic acid (LPA).
EFFECT: compound has excellent LPA receptor antagonist action and can be used as an agent for preventing and/or treating the diseases caused by LPA.
7 cl, 138 tbl, 308 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED AMIDE COMPOUNDS | 2010 |
|
RU2563639C2 |
PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
DERIVATIVES OF SUBSTITUTED TRIAZOLDIAMINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS PREPARING | 2001 |
|
RU2274639C2 |
GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES | 2018 |
|
RU2805308C2 |
2-AMINOTHIAZOLE DERIVATIVE OR SALT THEREOF | 2015 |
|
RU2702106C2 |
INHIBITORS OF DIACYLGLYCEROL O-ACYLTRANSFERASE TYPE 1 ENZYME | 2007 |
|
RU2474576C2 |
PYRAZOLOPYRIMIDINE-BASED JAK INHIBITING COMPOUNDS AND METHODS | 2010 |
|
RU2567238C2 |
INHIBITING JAK COMPOUNDS BASED ON PYRAZOLOPYRIMIDINE AND METHODS | 2010 |
|
RU2675857C2 |
SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS | 2012 |
|
RU2621695C2 |
DERIVATIVES OF INDOLE OR BENZIMIDAZOLE FOR MODULATION OF IkB KINASE | 2003 |
|
RU2318820C2 |
Authors
Dates
2017-01-30—Published
2010-09-24—Filed